P50443 (S26A2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 133.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Sulfate transporter Alternative name(s): Diastrophic dysplasia protein Solute carrier family 26 member 2 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 739 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Sulfate transporter. May play a role in endochondral bone formation. |
| Subcellular location | |
| Tissue specificity | Ubiquitously expressed. |
| Involvement in disease | Diastrophic dysplasia (DTD) [MIM:222600]: An autosomal recessive disease characterized by osteochondrodysplasia with clinical features including dwarfism, spinal deformation, and specific joint abnormalities. Achondrogenesis 1B (ACG1B) [MIM:600972]: A form of achondrogenesis type 1, a lethal form of chondrodysplasia characterized by deficient ossification in the lumbar vertebre and absent ossification in the sacral, pubic and ischial bones and clinically by stillbirth or early death. In addition to severe micromelia, there is a disproportionately large cranium due to marked edema of soft tissues. Atelosteogenesis 2 (AO2) [MIM:256050]: A perinatal dysplasia characterized by shortening of the limbs, a dysmorphic syndrome and radiographic skeletal features. Patients are stillborn or die soon after birth. Multiple epiphyseal dysplasia 4 (EDM4) [MIM:226900]: A generalized skeletal dysplasia associated with significant morbidity. Joint pain, joint deformity, waddling gait, and short stature are the main clinical signs and symptoms. Radiological examination of the skeleton shows delayed, irregular mineralization of the epiphyseal ossification centers and of the centers of the carpal and tarsal bones. Multiple epiphyseal dysplasia is broadly categorized into the more severe Fairbank and the milder Ribbing types. The Fairbank type is characterized by shortness of stature, short and stubby fingers, small epiphyses in several joints, including the knee, ankle, hand, and hip. The Ribbing type is confined predominantly to the hip joints and is characterized by hands that are normal and stature that is normal or near-normal. Multiple epiphyseal dysplasia type 4 is a recessively inherited form, characterized by early childhood-onset hip dysplasia and recurrent patella dislocation. Short stature is not frequent. |
| Sequence similarities | Belongs to the SLC26A/SulP transporter (TC 2.A.53) family. [View classification] Contains 1 STAS domain. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Transport |
| Cellular component | Membrane |
| Coding sequence diversity | Polymorphism |
| Disease | Disease mutation Dwarfism |
| Domain | Transmembrane Transmembrane helix |
| PTM | Glycoprotein Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | ossification Inferred from electronic annotation. Source: Compara sulfate transportTraceable author statement Ref.1. Source: ProtInc |
| Cellular_component | integral to plasma membrane Traceable author statement Ref.8. Source: ProtInc |
| Molecular_function | secondary active sulfate transmembrane transporter activity Inferred from electronic annotation. Source: InterPro sulfate transmembrane transporter activityTraceable author statement Ref.1. Source: ProtInc |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 739 | 739 | Sulfate transporter | PRO_0000080158 | |||||
Regions | |||||||||
| Topological domain | 1 – 111 | 111 | Cytoplasmic Potential | ||||||
| Transmembrane | 112 – 132 | 21 | Helical; Potential | ||||||
| Topological domain | 133 – 136 | 4 | Extracellular Potential | ||||||
| Transmembrane | 137 – 157 | 21 | Helical; Potential | ||||||
| Topological domain | 158 – 159 | 2 | Cytoplasmic Potential | ||||||
| Transmembrane | 160 – 180 | 21 | Helical; Potential | ||||||
| Topological domain | 181 – 218 | 38 | Extracellular Potential | ||||||
| Transmembrane | 219 – 239 | 21 | Helical; Potential | ||||||
| Topological domain | 240 – 241 | 2 | Cytoplasmic Potential | ||||||
| Transmembrane | 242 – 262 | 21 | Helical; Potential | ||||||
| Topological domain | 263 – 296 | 34 | Extracellular Potential | ||||||
| Transmembrane | 297 – 317 | 21 | Helical; Potential | ||||||
| Topological domain | 318 – 328 | 11 | Cytoplasmic Potential | ||||||
| Transmembrane | 329 – 349 | 21 | Helical; Potential | ||||||
| Topological domain | 350 – 377 | 28 | Extracellular Potential | ||||||
| Transmembrane | 378 – 398 | 21 | Helical; Potential | ||||||
| Topological domain | 399 – 420 | 22 | Cytoplasmic Potential | ||||||
| Transmembrane | 421 – 441 | 21 | Helical; Potential | ||||||
| Topological domain | 442 – 454 | 13 | Extracellular Potential | ||||||
| Transmembrane | 455 – 475 | 21 | Helical; Potential | ||||||
| Topological domain | 476 – 523 | 48 | Cytoplasmic Potential | ||||||
| Transmembrane | 524 – 544 | 21 | Helical; Potential | ||||||
| Topological domain | 545 – 643 | 99 | Extracellular Potential | ||||||
| Transmembrane | 644 – 664 | 21 | Helical; Potential | ||||||
| Topological domain | 665 – 739 | 75 | Cytoplasmic Potential | ||||||
| Domain | 568 – 719 | 152 | STAS | ||||||
Amino acid modifications | |||||||||
| Modified residue | 12 | 1 | Phosphoserine Ref.7 | ||||||
| Modified residue | 16 | 1 | Phosphoserine Ref.7 | ||||||
| Glycosylation | 199 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 205 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 357 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Natural variant | 255 | 1 | G → E in AO2. Ref.9 | VAR_007434 | |||||
| Natural variant | 256 | 1 | F → S in EDM4. Ref.12 | VAR_066835 | |||||
| Natural variant | 279 | 1 | R → W in AO2 and EDM4. Ref.9 Ref.12 | VAR_007435 | |||||
| Natural variant | 340 | 1 | Missing in ACG1B. Ref.8 | VAR_007436 | |||||
| Natural variant | 425 | 1 | N → D in ACG1B. Ref.8 | VAR_007437 | |||||
| Natural variant | 454 | 1 | Q → P in diatrophic dysplasia; broad bone-platyspondylic variant. Ref.10 | VAR_018654 | |||||
| Natural variant | 574 | 1 | I → T. Ref.1 Ref.2 Ref.5 Corresponds to variant rs30832 [ dbSNP | Ensembl ]. | VAR_058415 | |||||
| Natural variant | 653 | 1 | C → S in EDM4. Ref.11 Ref.12 | VAR_018655 | |||||
| Natural variant | 678 | 1 | G → V in ACG1B. Ref.8 | VAR_007438 | |||||
| Natural variant | 689 | 1 | T → S. Corresponds to variant rs3776070 [ dbSNP | Ensembl ]. | VAR_020402 | |||||
| Natural variant | 715 | 1 | A → V in AO2 and EDM4. Ref.9 Ref.12 | VAR_007439 | |||||
Experimental info | |||||||||
| Sequence conflict | 619 | 1 | R → G in CAE45819. Ref.6 | ||||||
| Sequence conflict | 622 | 1 | K → R in BAG35488. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping." Haestbacka J., de la Chapelle A., Mahtani M.M., Clines G., Reeve-Daly M.P., Daly M., Hamilton B.A., Kusumi K., Trivedi B., Weaver A., Coloma A., Lovett M., Buckler A., Kaitila I., Lander E.S. Cell 78:1073-1087(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT THR-574. Tissue: Brain. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT THR-574. Tissue: Tongue. |
| [3] | "The DNA sequence and comparative analysis of human chromosome 5." Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S. Rubin E.M.Nature 431:268-274(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT THR-574. Tissue: Placenta. |
| [6] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 614-739. Tissue: Prostate. |
| [7] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12 AND SER-16, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [8] | "Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene." Superti-Furga A., Haestbacka J., Wilcox W.R., Cohn D.H., van der Harten H.J., Rossi A., Blau N., Rimoin D.L., Steinmann B., Lander E.S., Gitzelmann R. Nat. Genet. 12:100-102(1996) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS ACG1B VAL-340 DEL; ASP-425 AND VAL-678. |
| [9] | "Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias." Haestbacka J., Superti-Furga A., Wilcox W.R., Rimoin D.L., Cohn D.H., Lander E.S. Am. J. Hum. Genet. 58:255-262(1996) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS AO2 GLU-255; TRP-279 AND VAL-715. |
| [10] | "Homozygosity for a novel DTDST mutation in a child with a 'broad bone-platyspondylic' variant of diastrophic dysplasia." Megarbane A., Haddad F.A., Haddad-Zebouni S., Achram M., Eich G., Le Merrer M., Superti-Furga A. Clin. Genet. 56:71-76(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT DIATROPHIC DYSPLASIA PRO-454. |
| [11] | "Autosomal recessive multiple epiphyseal dysplasia with homozygosity for C653S in the DTDST gene: double-layer patella as a reliable sign." Maekitie O., Savarirayan R., Bonafe L., Robertson S., Susic M., Superti-Furga A., Cole W.G. Am. J. Med. Genet. A 122:187-192(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT EDM4 SER-653. |
| [12] | "Pseudoachondroplasia and multiple epiphyseal dysplasia: A 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution." Jackson G.C., Mittaz-Crettol L., Taylor J.A., Mortier G.R., Spranger J., Zabel B., Le Merrer M., Cormier-Daire V., Hall C.M., Offiah A., Wright M.J., Savarirayan R., Nishimura G., Ramsden S.C., Elles R., Bonafe L., Superti-Furga A., Unger S., Zankl A., Briggs M.D. Hum. Mutat. 33:144-157(2012) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS EDM4 SER-256; TRP-279; SER-653 AND VAL-715. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U14528 mRNA. Translation: AAA70081.1. AK290358 mRNA. Translation: BAF83047.1. AK312596 mRNA. Translation: BAG35488.1. AC008427 Genomic DNA. No translation available. CH471062 Genomic DNA. Translation: EAW61755.1. BC059390 mRNA. Translation: AAH59390.1. BX640696 mRNA. Translation: CAE45819.1. |
| IPI | IPI00032107. |
| PIR | A54808. |
| RefSeq | NP_000103.2. NM_000112.3. |
| UniGene | Hs.302738. |
3D structure databases | |
| ProteinModelPortal | P50443. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000286298. |
Protein family/group databases | |
| TCDB | 2.A.53.2.1. sulfate permease (SulP) family. |
PTM databases | |
| PhosphoSite | P50443. |
Polymorphism databases | |
| DMDM | 254763328. |
Proteomic databases | |
| PaxDb | P50443. |
| PRIDE | P50443. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000286298; ENSP00000286298; ENSG00000155850. |
| GeneID | 1836. |
| KEGG | hsa:1836. |
| UCSC | uc003lrh.3. human. |
Organism-specific databases | |
| CTD | 1836. |
| GeneCards | GC05P149320. |
| H-InvDB | HIX0005307. |
| HGNC | HGNC:10994. SLC26A2. |
| HPA | HPA041957. |
| MIM | 222600. phenotype. 226900. phenotype. 256050. phenotype. 600972. phenotype. 606718. gene. |
| neXtProt | NX_P50443. |
| Orphanet | 93298. Achondrogenesis type 1B. 56304. Atelosteogenesis type II. 628. Diastrophic dwarfism. 93307. Multiple epiphyseal dysplasia type 4. |
| PharmGKB | PA149. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0659. |
| HOGENOM | HOG000006546. |
| HOVERGEN | HBG000639. |
| InParanoid | P50443. |
| KO | K14701. |
| OMA | TSDRICD. |
| OrthoDB | EOG4BZN22. |
| PhylomeDB | P50443. |
Enzyme and pathway databases | |
| Reactome | REACT_15518. Transmembrane transport of small molecules. |
Gene expression databases | |
| ArrayExpress | P50443. |
| Bgee | P50443. |
| CleanEx | HS_SLC26A2. |
| Genevestigator | P50443. |
| GermOnline | ENSG00000155850. Homo sapiens. |
Family and domain databases | |
| Gene3D | 3.30.750.24. 2 hits. |
| InterPro | IPR018045. S04_transporter_CS. IPR002645. STAS_dom. IPR001902. SulP_transpt. IPR011547. Sulph_transpt. [Graphical view] |
| Pfam | PF01740. STAS. 1 hit. PF00916. Sulfate_transp. 1 hit. [Graphical view] |
| SUPFAM | SSF52091. STAS. 1 hit. |
| TIGRFAMs | TIGR00815. sulP. 1 hit. |
| PROSITE | PS01130. SLC26A. 1 hit. PS50801. STAS. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | SLC26A2. human. |
| GenomeRNAi | 1836. |
| NextBio | 7495. |
| SOURCE | Search... |
Entry information
| Entry name | S26A2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P50443 Secondary accession number(s): A8K2U3, B2R6J1, Q6N051 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
